期刊首页 优先出版 当期阅读 过刊浏览 作者中心 关于期刊 English

2010年 第4卷 第1期

摘要

关键词

相关研究

回顶部

《医学前沿（英文）》 >> 2010年 第4卷 第1期 doi: 10.1007/s11684-010-0010-0

Mitogen-activated protein kinase pathway inhibitors: inhibitors for diseases?

1.College of Life Science, Northeast Forestry University, Harbin 150040, China；Key Laboratory of Functional Proteomics of Guangdong Province, Department of Pathophysiology, Southern Medical University, Guangzhou 510515, China; 2.Key Laboratory of Functional Proteomics of Guangdong Province, Department of Pathophysiology, Southern Medical University, Guangzhou 510515, China; 3.College of Life Science, Northeast Forestry University, Harbin 150040, China;

发布日期： 2010-03-05
HTML11 PDF 4 收藏 0

下一篇 上一篇

摘要

Mitogen-activated protein kinase (MAPK) signaling pathway, one of the most important signaling pathways in eukaryotic organism, is involved in multiple cellular events such as cell growth, differentiation, and apoptosis. MAPK is of great importance to the normal function of organisms, while its dysfunction results in various diseases. So far, inhibitors specifically against each subfamilies of MAP kinase have been developed, while more endeavors are needed to discover the compounds selectively targeting a particular subfamily member. Most of the kinase inhibitors exert their functions in an ATP-competitive way or a non-ATP-competitive way. Further studies on the effective mechanism of the MAPK inhibitors and their therapeutic roles in the treatment of diseases are helpful for the illumination of MAP kinase function, the development of novel inhibitors, and the therapy of diseases caused by the dysfunction of the MAPK pathway.

相关研究